Medtronic

At the end of the year 2000 Medtronic announced its intention to enter the neuro-endovascular field and launched its first stent designed specifically for intracranial use on the European market, the INX neurovascular stent.

The INX stent received CE Mark approval following the completion of a clinical study conducted at seven sites throughout the world. This initial study was designed solely to demonstrate safety and device performance in a high-risk patient population.  The device is still investigational in the US. Additional clinical trials with the INX stent are underway to examine additional applications.